CN101195615B - 咪唑-5-羧酸衍生物的盐、制备方法及其药物组合物 - Google Patents
咪唑-5-羧酸衍生物的盐、制备方法及其药物组合物 Download PDFInfo
- Publication number
- CN101195615B CN101195615B CN 200610119184 CN200610119184A CN101195615B CN 101195615 B CN101195615 B CN 101195615B CN 200610119184 CN200610119184 CN 200610119184 CN 200610119184 A CN200610119184 A CN 200610119184A CN 101195615 B CN101195615 B CN 101195615B
- Authority
- CN
- China
- Prior art keywords
- salt
- imidazole
- carboxylic acid
- methyl
- butyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
分析项目 | 测定值% | 计算值% |
C | 54.76 | 54.81 |
H | 4.75 | 4.74 |
N | 14.20 | 14.21 |
分析项目 | 测定值% | 计算值% |
C | 56.44 | 56.40 |
H | 4.90 | 4.91 |
N | 14.60 | 14.62 |
分析项目 | 测定值% | 计算值% |
C | 56.60 | 56.64 |
H | 5.10 | 5.07 |
N | 14.66 | 14.68 |
化合物 | Tmax | 生物利用度 |
化合物1 | 2h | 4.11% |
化合物2 | 0.5h | 26.7% |
化合物3 | 0.5h | 22.6% |
化合物4 | 0.5h | 21.3% |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200610119184 CN101195615B (zh) | 2006-12-06 | 2006-12-06 | 咪唑-5-羧酸衍生物的盐、制备方法及其药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200610119184 CN101195615B (zh) | 2006-12-06 | 2006-12-06 | 咪唑-5-羧酸衍生物的盐、制备方法及其药物组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101195615A CN101195615A (zh) | 2008-06-11 |
CN101195615B true CN101195615B (zh) | 2013-03-27 |
Family
ID=39546257
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200610119184 Active CN101195615B (zh) | 2006-12-06 | 2006-12-06 | 咪唑-5-羧酸衍生物的盐、制备方法及其药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101195615B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2103610B1 (en) * | 2006-12-06 | 2011-09-21 | Shanghai Allist Pharmaceutical., Inc. | Salts of imidazol-5-carboxylic acid derivatives, preparation methods and use thereof |
CN101596189A (zh) * | 2008-06-05 | 2009-12-09 | 上海艾力斯生物医药有限公司 | 含有咪唑-5-羧酸类衍生物的药用组合物 |
CN111018841B (zh) * | 2013-11-01 | 2023-04-07 | 深圳信立泰药业股份有限公司 | 阿利沙坦酯无定形及其制备方法及含所述无定形的药物组合物 |
CN106188012B (zh) * | 2014-06-20 | 2018-11-30 | 深圳信立泰药业股份有限公司 | 一种阿利沙坦酯结晶及其制备方法及含有该结晶的药物组合物 |
CN115974848B (zh) * | 2017-10-24 | 2024-04-02 | 深圳信立泰药业股份有限公司 | 阿利沙坦酯钙盐晶型及含有所述钙盐晶型的药物组合物 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1071426A (zh) * | 1991-10-04 | 1993-04-28 | 化学药物研究股份公司 | 咪唑-5-羧酸衍生物的新的缩醛的制备方法 |
-
2006
- 2006-12-06 CN CN 200610119184 patent/CN101195615B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1071426A (zh) * | 1991-10-04 | 1993-04-28 | 化学药物研究股份公司 | 咪唑-5-羧酸衍生物的新的缩醛的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101195615A (zh) | 2008-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100506818C (zh) | 咪唑-5-羧酸类衍生物、制备方法及其应用 | |
JP4437141B2 (ja) | オルメサルタンメドキソミルの精製法 | |
US20060094883A1 (en) | Process for preparing telmisartan | |
CN101195615B (zh) | 咪唑-5-羧酸衍生物的盐、制备方法及其药物组合物 | |
CN105294585B (zh) | 一种治疗痛风的化合物 | |
CA2875507A1 (en) | Solid forms of an antiviral compound | |
JP5290190B2 (ja) | イミダゾール−5−カルボン酸誘導体の塩、製造方法及びその医薬組成物 | |
CN101544572A (zh) | 一种氨溴索衍生物及其制备方法 | |
CN101402641A (zh) | 含噻吩并吡啶的肟类衍生物、其制备方法和用途 | |
CN104017031A (zh) | 降血糖药物和组合物 | |
GB2603382A (en) | Pyridine sulfonamide phosphate compound, preparation method therefor and application thereof | |
CN104031098A (zh) | 降糖药物 | |
CN101712676B (zh) | 水溶性葛根素衍生物及其制备方法与用途 | |
CN101715448B (zh) | 一种咪唑-5-羧酸衍生物的治疗用途 | |
CN101597271A (zh) | 艾拉莫德的衍生物,其制备方法和药物应用 | |
EP1622899A1 (en) | Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same | |
CN102101858B (zh) | 雷莫司琼衍生物及其制备方法和用途 | |
CN103570657A (zh) | 一类含偕二甲基的苯基c-葡萄糖苷衍生物、其制备方法和用途 | |
CN114671839B (zh) | 达格列净的固体形式复合物及其制备方法与应用 | |
CN102558064B (zh) | 抗高血压化合物及其制备方法和应用,以及其在药学上可接受的盐 | |
CN102850333A (zh) | 奥美沙坦酯晶体及其制备方法 | |
JP2001525405A (ja) | (E)−3−[1−n−ブチル−5−[2−(2−カルボキシフェニル)メトキシ−4−クロロフェニル]−1H−ピラゾール−4−イル]−2−[(5−メトキシ−2,3−ジヒドロベンゾフラン−6−イル)メチル]−プロプ−2−エン酸一アルギニル塩 | |
CN1711247A (zh) | 塞来考昔的前药 | |
CN101781300B (zh) | 一种恩替卡韦的盐化合物,其制备方法和药物应用 | |
WO2006136916A2 (en) | Substantially pure micronized particles of telmisartan and pharmaceutical compositions containing same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI ALLIS BIO-PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: SHANGHAI ALLIS MEDICAL TECHNOLOGY CO., LTD. Effective date: 20090918 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20090918 Address after: Pudong New Area Zhou Zhu highway 337, Shanghai, China Code: 201318 Applicant after: Shanghai Allist Biomedical Co., Ltd. Address before: Shanghai City, Pudong Zhangjiang Cailun Road No. 4 Building 780 post encoding: 201203 Applicant before: Shanghai Allist Pharmaceuticals Co., Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI ALLIST PHARMACEUTICALS CO., LTD. Free format text: FORMER OWNER: SHANGHAI ALLIST BIOMEDICAL CO., LTD. Effective date: 20130104 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 201318 PUDONG NEW AREA, SHANGHAI TO: 201203 PUDONG NEW AREA, SHANGHAI |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20130104 Address after: 201203 Shanghai City Harley Road, Zhangjiang hi tech Park No. 1118 5 floor Applicant after: Shanghai Allist Pharmaceuticals Co., Ltd. Address before: 201318 Shanghai city Pudong New Area Zhu Zhou Road No. 337 Applicant before: Shanghai Allist Biomedical Co., Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: SHENZHEN SALUBRIS ASSETS MANAGEMENT CO., LTD. Free format text: FORMER OWNER: SHANGHAI ALLIST PHARMACEUTICALS CO., LTD. Effective date: 20130124 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 201203 PUDONG NEW AREA, SHANGHAI TO: 518040 SHENZHEN, GUANGDONG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20130124 Address after: 518040, Anhui building, south of Shennan Road, Shenzhen, Guangdong, 1921, Futian District Applicant after: Shenzhen Salubris Pharmaceuticals Co., Ltd. Address before: 201203 Shanghai City Harley Road, Zhangjiang hi tech Park No. 1118 5 floor Applicant before: Shanghai Allist Pharmaceuticals Co., Ltd. |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20080611 Assignee: Jiangsu Ellis Bio-Pharmaceutical Co., Ltd. Assignor: Shenzhen Salubris Pharmaceuticals Co., Ltd. Contract record no.: 2013440020021 Denomination of invention: Salt of imidazole-carboxylic acid derivant, production method and pharmaceutical composition thereof License type: Common License Record date: 20130123 Application publication date: 20080611 Assignee: Shenzhen Salubris Pharmaceuticals Co., Ltd. Assignor: Shenzhen Salubris Pharmaceuticals Co., Ltd. Contract record no.: 2013440020019 Denomination of invention: Salt of imidazole-carboxylic acid derivant, production method and pharmaceutical composition thereof License type: Common License Record date: 20130123 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHENZHEN SALUBRIS ASSETS MANAGEMENT CO., LTD. Effective date: 20141231 Owner name: HUIZHOU XINLITAI PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: SHENZHEN SALUBRIS ASSETS MANAGEMENT CO., LTD. Effective date: 20141231 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 518040 SHENZHEN, GUANGDONG PROVINCE TO: 516083 HUIZHOU, GUANGDONG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20141231 Address after: 516083, No. 42, West Petrochemical Avenue, Dayawan West, Huizhou, Guangdong, Huizhou Patentee after: HUIZHOU XINLITAI PHARMACEUTICAL CO., LTD. Patentee after: Shenzhen Salubris Pharmaceuticals Co., Ltd. Address before: 518040, Anhui building, south of Shennan Road, Shenzhen, Guangdong, 1921, Futian District Patentee before: Shenzhen Salubris Pharmaceuticals Co., Ltd. |
|
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Jiangsu Ellis Bio-Pharmaceutical Co., Ltd. Assignor: Shenzhen Salubris Pharmaceuticals Co., Ltd. Contract record no.: 2013440020021 Date of cancellation: 20150127 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
ASS | Succession or assignment of patent right |
Owner name: SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. Free format text: FORMER OWNER: SHENZHEN SALUBRIS ASSETS MANAGEMENT CO., LTD. Effective date: 20150716 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150716 Address after: 516083, No. 42, West Petrochemical Avenue, Dayawan West, Huizhou, Guangdong, Huizhou Patentee after: HUIZHOU XINLITAI PHARMACEUTICAL CO., LTD. Patentee after: Shenzhen Salubris Pharmaceuticals Co., Ltd. Address before: 516083, No. 42, West Petrochemical Avenue, Dayawan West, Huizhou, Guangdong, Huizhou Patentee before: HUIZHOU XINLITAI PHARMACEUTICAL CO., LTD. Patentee before: Shenzhen Salubris Pharmaceuticals Co., Ltd. |